10 of the best performing medical device stocks of 2018

Abiomed: +73%

Abiomed (Nasdaq:ABMD) saw its stock soar to $325.04 per share by the end of the year after strong financial results. Its profits more than doubled year-over-year to about $140 million for the six months ended Sept. 30, following massive growth in profits for its full fiscal year 2018.

The company is the maker of Impella heart pumps —  a support system of percutaneous, catheter-based devices that offer hemodynamic support to people’s hearts. It spent more than $75 million on R&D during its most recent fiscal year, representing nearly 13% of its revenue.

Earlier this year, Abiomed announced approval of its Impella heart pump in India. It also issued plans to open a new $17 million innovation center near its Danvers, Mass. headquarters.

Wall Street isn’t entirely impressed with the company, though: Shares fell approximately 13.1% in mid-November 2018 despite the company announcing positive results from a pilot trial of its Impella CP heart pump that will clear the way for a pivotal trial that could nearly double the device’s total addressable market. Investors had higher hopes than the small pilot trial could provide, coupled with a broader selloff in medtech and disappointment that the pivotal trial will be delayed until the second half of 2019, Leerinck analyst Danielle Antalffy wrote in a letter to investors. She remains bullish on the company.

Abiomed invested $15 million in Shockwave Medical in December last year. The investment will help fund a collaboration between the two companies on a training and education program in the U.S. and Germany.

Next>>

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW